References
- Agata, Y., Kawasaki, A., Nishimura, H., Ishida, Y., Tsubata, T., Yagita, H., and Honjo, T. 1996. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int. Immunol. 8, 765-772. https://doi.org/10.1093/intimm/8.5.765
- Angus, D.C., Linde-Zwirble, W.T., Lidicker, J., Clermont, G., Carcillo, J., and Pinsky, M.R. 2001. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit. Care. Med. 29, 1303-1310. https://doi.org/10.1097/00003246-200107000-00002
- Annane, D., Bellissant, E., and Cavailon, J.M. 2005. Septic shock. Lancet 365, 63-78. https://doi.org/10.1016/S0140-6736(04)17667-8
- Azuma, M., Ito, D., Yagita, H., Okumura, K., Phillips, J.H., Lanier, L.L., and Somoza, C. 1993. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366, 76-79. https://doi.org/10.1038/366076a0
- Blanco, J.C., Contursi, C., Salkowski, C.A., DeWitt, D.L., Ozato, K., and Vogel, S.N. 2000. Interferon regulatory factor (IRF)-1 and IRF-2 regulate interferon gamma-dependent cyclooxygenase 2 expression. J. Exp. Med. 191, 2131-2144. https://doi.org/10.1084/jem.191.12.2131
- Carter, L., Fouser, L.A., Jussif, J., Fitz, L., Deng, B., Wood, C.R., Collins, M., Honjo, T., Freeman, G.J., and Carreno, B.M. 2002. PD-1: PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Eur. J. Immunol. 32, 634-643. https://doi.org/10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9
-
Cho, H.Y., Lee, S.W., Seo, S.K., Choi, I.W., Choi, I.h., and Lee, S.W. 2008. Interferon-sensitive response element (ISRE) is mainly responsible for IFN-
$alpha$ -induced upregulation of programmed death-1 (PD-1) in macrophages. Biochimi. Biophys. Acta 1779, 811-819. https://doi.org/10.1016/j.bbagrm.2008.08.003 - Cohen, J. 2002. The immunopathogenesis of sepsis. Nature 420, 885-891. https://doi.org/10.1038/nature01326
- Freeman, G.J., Freedman, A.S., Segil, J.M., Lee, G., Whitman, J.F., and Nadler, L.M. 1989. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J. Immunol. 143, 2714-2722.
- Freeman, G.J., Long, A.J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitz, L.J., Malenkovich, N., Okazaki, T., Byrne, M.C., and et al. 2000. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192, 1027-1034. https://doi.org/10.1084/jem.192.7.1027
- Hsu, H.Y. and Wen, M.H. 2002. Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression. J. Biol. Chem. 277, 22131-22139. https://doi.org/10.1074/jbc.M111883200
- Huang, X., Venet, F., Wang, Y.L., Lepape, A., Yuan, Z., Chen, Y., Swan, R., Kherouf, H., Monneret, G., Chung, C.S., and et al. 2009. PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis. Proc. Natl. Acad. Sci. USA 14, 6303-6308.
- Ishida, Y., Agata, Y., Shibahara, K., and Honjo, T. 1992. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 11, 3887-3895.
- Jiang, Z., Georgel, P., Du, X., Shamel, L., Sovath, S., Mudd, S., Huber, M., Kalis, C., Keck, S., Galanos, C., and et al. 2005. CD14 is required for MyD88-independent LPS signaling. Nature Immunol. 6, 565-570. https://doi.org/10.1038/ni1207
- Judith, M.C., Linda, B., Thomas, J.G., William, C.C., and Gerard, M.D. 2005. Interferon regulatory factor 1 (IRF-1) and IRF-2 expression in breast cancer tissue microarrays. J. Interferon Cytokine Res. 25, 587-594. https://doi.org/10.1089/jir.2005.25.587
- Keir, M.E., Francisco, L.M., and Sharpe, A.H. 2007. PD-1 and its ligands in T-cell immunity. Curr. Opin. Immunol. 19, 309-314. https://doi.org/10.1016/j.coi.2007.04.012
- Kim, Y.H., Choi, M.R., Song, D.K., Huh, S.O., Jang, C.G., and Suh, H.W. 2000. Regulation of c-fos gene expression by lipopolysaccharide and cycloheximide in C6 rat glioma cells. Brain Res. 872, 227-230. https://doi.org/10.1016/S0006-8993(00)02477-X
- Kou, X., Qi, S., Dai, W., Luo, L., and Yin, Z. 2011. Arctigenin inhibits lipopolysaccharide-induced iNOS expression in RAW264.7 cells through suppressing JAK-STAT signal pathway. Int. Immunopharmacol. 11, 1095-1102. https://doi.org/10.1016/j.intimp.2011.03.005
- Latchman, Y., Wood, C.R., Chernova, T., Chaudhary, D., Borde, M., Chernova, I., Iwai, Y., Long, A.J., Brown, J.A., Nunes, R., and et al. 2001. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2, 261-268. https://doi.org/10.1038/85330
- Lawrence, T., Gilroy, D.W., Colville-Nash, P.R., and Willoughby, D.A. 2001. Possible new role for NF-kappaB in the resolution of inflammation. Nat. Med. 7, 1291-1297. https://doi.org/10.1038/nm1201-1291
- Martin, G.S., Mannino, D.M., Eaton, S., and Moss, M. 2003. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348, 1546-1554. https://doi.org/10.1056/NEJMoa022139
- Mueller, D.L., Jenkins, M.K., and Schwartz, R.H. 1989. Clonal expansion versus functional clonal inactivation: a costimulatory signaling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7, 445-480. https://doi.org/10.1146/annurev.iy.07.040189.002305
- Nishimura, H., Minato, N., Nakano, T., and Honjo, T. 1998. Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses. Int. Immunol. 10, 1563-1572. https://doi.org/10.1093/intimm/10.10.1563
- Okazaki, T., Maeda, A., Nishimura, H., Kurosaki, T., and Honjo, T. 2001. PD-1 immunoreceptor inhibits B cell receptormediated signaling by recruiting src homology 2-domaincontaining tyrosine phosphatase 2 to phosphotyrosine. Proc. Natl. Acad. Sci. USA 98, 13866-13871. https://doi.org/10.1073/pnas.231486598
- Parant, M., Parant, F., and Chedid, L. 1977. Inheritance of lipopolysaccharide-enhanced nonspecific resistance to infection and of susceptibility to endotoxic shock in lipopolysaccharide low-responder mice. Infect. Immun. 16, 432-438.
- Parry, R.V., Chemnitz, J.M., Frauwirth, K.A., Lanfranco, A.R., Braunstein, I., Kobayashi, S.V., Linsley, P.S., Thompson, C.B., and Riley, J.L. 2005. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol. Cell Biol. 25, 9543-9553. https://doi.org/10.1128/MCB.25.21.9543-9553.2005
- Salkowski, C.A., Kopydlowski, K., Blanco, J., Cody, M.J., McNally, R., and Vogel, S.N. 1999. IL-12 is dysregulated in macrophages from IRF-1 and IRF-2 knockout mice. J. Immunol. 163, 1529-1536.
- Singh, A.K., Stock, P., and Akbari, O. 2011. Role of PD-L1 and PD-L2 in allergic diseases and asthma. Allergy 66, 155-162. https://doi.org/10.1111/j.1398-9995.2010.02458.x
- Yao, S., Wang, S., Zhu, Y., Luo, L., Zhu, G., Flies, S., Xu, H., Ruff, W., Broadwater, M., Choi, I.H., and et al. 2009. PD-1 on dendritic cells impedes innate immunity against bacterial infection. Blood 113, 5811-5818. https://doi.org/10.1182/blood-2009-02-203141
- Zhang, X., Schwartz, J.C., Guo, X., Bhatia, S., Cao, E., Lorenz, M., Cammer, M., Chen, L., Zhang, Z.Y., Edidin, M.A., and et al. 2004. Structural and functional analysis of the costimulatory receptor programmed death-1. Immunity 20, 337-347. https://doi.org/10.1016/S1074-7613(04)00051-2